First reported at 200,000 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2026-09-30 | 3428000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | New | 200,000 | +200,000 (0.0%) | 2.59% | $3,428,000 | 2026-11-13 |
Who else reported the position
64 managers reported ATTOVIA THERAPEUTIS INC COM for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Frazier Life Sciences Management L P | New | 7,046,271 | +7,046,271 | 3.0% | $120,773,085 | 1 qtr |
| The Goldman Sachs Group Inc | New | 5,391,772 | +5,391,772 | < 0.01% | $92,414,972 | 1 qtr |
| venBio Partners LLC | New | 4,181,366 | +4,181,366 | 14.45% | $71,668,613 | 1 qtr |
| Deep Track Capital LP | New | 3,207,138 | +3,207,138 | 0.9% | $54,970,345 | 1 qtr |
| EcoR1 Capital LLC | New | 2,024,010 | +2,024,010 | 1.54% | $34,691,531 | 1 qtr |
| Nextech Invest Ltd | New | 1,835,139 | +1,835,139 | 1.41% | $31,454,282 | 1 qtr |
| Cormorant Asset Management LP | New | 1,788,815 | +1,788,815 | 2.06% | $30,660,285 | 1 qtr |
| Redmile Group LLC | New | 1,163,587 | +1,163,587 | 1.46% | $19,943,881 | 1 qtr |
| COMMODORE CAPITAL LP | New | 1,160,000 | +1,160,000 | 1.54% | $19,882,400 | 1 qtr |
| Sanofi | New | 1,082,855 | +1,082,855 | 2.95% | $18,560,135 | 1 qtr |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 13, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 200,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.